Efficacy and Safety of Once-Weekly Dulaglutide vs. Insulin Glargine in Combination with Metformin and Glimepiride in Type 2 Diabetes Patients (AWARD-2)

被引：0
|
作者：
Giorgino, Francesco
Benroubi, Maria
Sun, Jui-Hung
Zimmermann, Alan G.
Pechtner, Valeria
机构：
来源：
DIABETES | 2014年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
330-OR
引用
收藏
页码：A87 / A87
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety profile of once-weekly dulaglutide in type 2 diabetes: a report on the emerging new data
    Kugler, Anne J.
    Thiman, Michael L.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2018, 11 : 187 - 197
  • [32] Efficacy and Safety of Tirzepatide vs. Semaglutide Once-Weekly as Add-On Therapy to Metformin in People with Type 2 Diabetes (SURPASS-2)
    Frias, Juan Pablo
    Davies, Melanie J.
    Rosenstock, Julio
    Perez Manghi, Federico C.
    Lando, Laura Fernandez
    Bergman, Brandon
    Liu, Bing
    Cui, Xuewei
    Brown, Katelyn
    DIABETES, 2021, 70
  • [33] Once-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes
    Arslanian, Silva A.
    Hannon, Tamara
    Zeitler, Philip
    Chao, Lily C.
    Boucher-Berry, Claudia
    Barrientos-Perez, Margarita
    Bismuth, Elise
    Dib, Sergio
    Cho, Jang Ik
    Cox, David
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (05): : 433 - 443
  • [34] Efficacy and safety of semaglutide once-weekly vs placebo as add-on to basal insulin alone or in combination with metformin in subjects with type 2 diabetes (SUSTAIN 5)
    Rodbard, H.
    Lingvay, I.
    Reed, J.
    de la Rosa, R.
    Rose, L.
    Sugimoto, D.
    Araki, E.
    Chus, P. -L.
    Wijayasingh, N.
    Norwood, P.
    DIABETOLOGIA, 2016, 59 : S364 - S365
  • [35] Efficacy and safety of semaglutide once-weekly vs placebo as add-on to basal insulin alone or in combination with metformin in subjects with Type 2 diabetes (SUSTAIN 5)
    Rodbard, H.
    Lingvay, I.
    Reed, J.
    de la Rosa, R.
    Rose, L.
    Sugimoto, D.
    Araki, E.
    Chu, P-L
    Wijayasingh, N.
    Norwood, P.
    Subramanian, G.
    DIABETIC MEDICINE, 2017, 34 : 145 - 146
  • [36] Once-Weekly Dulaglutide for Treatment of Youths with Type 2 Diabetes
    Senoo, Yuki
    Kami, Masahiro
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (16): : 1529 - 1530
  • [37] Safety and Efficacy of Once-Weekly Exenatide Compared With Insulin Glargine Titrated to Target in Patients With Type 2 Diabetes Over 84 Weeks
    Diamant, Michaela
    Van Gaal, Luc
    Stranks, Stephen
    Guerci, Bruno
    MacConell, Leigh
    Haber, Harry
    Scism-Bacon, Jamie
    Trautmann, Michael
    DIABETES CARE, 2012, 35 (04) : 683 - 689
  • [38] Similar efficacy and safety of once-weekly dulaglutide in patients with type 2 diabetes aged ≥65 and <65 years
    Boustani, M. A.
    Pittman, I.
    Yu, M.
    Thieu, V. T.
    Varnado, O. J.
    Juneja, R.
    DIABETES OBESITY & METABOLISM, 2016, 18 (08): : 820 - 828
  • [39] Efficacy and Safety of Once-Weekly Efpeglenatide vs. Placebo as Monotherapy in Patients with Type 2 Diabetes (AMPLITUDE-M)
    Baek, Seungjae
    Frias, Juan P.
    Popescu, Luiza
    Niemoeller, Elisabeth
    Muehlen-Bartmer, Isabel
    Rosenstock, Julio
    DIABETES, 2021, 70
  • [40] Efficacy and safety of once weekly dulaglutide versus once daily liraglutide in type 2 diabetes (AWARD6)
    Tofe Povedano, S.
    Dungan, K. M.
    Forst, T.
    Gonzalez Gonzalez, J. G.
    Atisso, C.
    Sealls, W.
    Fahrbach, J. L.
    DIABETOLOGIA, 2014, 57 : S23 - S23
12345